Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
This clinical trial update shows a recruiting longitudinal pediatric cohort study of primary immune thrombocytopenia in children. The study …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 clinical trial in China evaluating rituximab with an anti-CD38 monoclonal antibody versus rituximab alone for primary immune thrombo…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) [Phase 2]
This Phase 2 clinical trial is evaluating an anti-CD38 monoclonal antibody versus Rituximab for the management of primary immune thrombocyto…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy [Phase 2]
Phase II clinical trial evaluating orelabrutinib in combination with romiplostim for primary immune thrombocytopenia; study status is not ye…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis [NA]
This clinical trial is investigating anti-platelet antibodies detected with the MAIPA assay to demonstrate the autoimmune nature of thromboc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of bortezomib for relapsed/refractory immune thrombocytopenia and is currentl…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer
A completed clinical trial examining the molecular relationship between platelets and tumor cells in patients with immune thrombocytopenia a…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP [Phase 2]
A Phase 2 multicenter randomized open-label trial compares diammonium glycyrrhizinate enteric-coated capsules plus dexamethasone versus dexa…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) [Phase 2]
This Clinical Trial Update reports a Phase 2 study comparing daratumumab to rituximab for pediatric primary immune thrombocytopenia, with re…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) [Phase 2]
A Phase 2 trial in China is evaluating an anti-CD38 monoclonal antibody in combination with rituximab for primary immune thrombocytopenia an…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11) [Phase 2]
Phase 2 trial (TAI-SHAN11) of DZD8586 in adults with primary immune thrombocytopenia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: V-IMMUNE® for Immune Thrombocytopenia [Phase 3]
A Phase 3 clinical trial of V-IMMUNE for immune thrombocytopenia is actively recruiting.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP) [Phase 1, Phase 2]
This document provides an update on an ongoing Phase Ib/II clinical trial of STSA-1301, a subcutaneous therapy, for primary immune thrombocy…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia [Phase 1]
This entry reports on a Phase 1 clinical trial evaluating the optimal dose of zanubrutinib for adults with immune thrombocytopenia.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia
This clinical trial update outlines research into the role of genetic expression of interleukin-1β and interleukin-33 in the pathogenesis of…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases [NA]
A clinical trial update evaluating CD19 UCAR-T cell therapy in autoimmune diseases; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia [Phase 1, Phase 2]
Clinical trial update for CM336 in relapsed or refractory autoimmune cytopenia, including immune thrombocytopenia, autoimmune hemolytic anem…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
This entry describes a national multicenter retrospective real-world study in China to assess the treatment status of newly diagnosed and pe…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia [NA]
This clinical trial investigates the combination of Romiplostim N01 with Rituximab for primary immune thrombocytopenia that is refractory to…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) [Phase 2]
A Phase 2 clinical trial is evaluating an anti-CD38 antibody for treating pediatric primary immune thrombocytopenia (ITP). The study is curr…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP) [EARLY_Phase 1]
PRG-1801 is being evaluated for safety and efficacy in patients with recurrent or refractory primary immune thrombocytopenia, in an early-ph…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Severe Immune Cytopenia Registry Www.Sic-reg.Org
This entry provides a completed update on the Severe Immune Cytopenia Registry (SIC-reg), sponsored by the Medical University of Graz, cover…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children
This clinical trial update describes a planned study to evaluate safety and efficacy of romiplostim for chronic immune thrombocytopenia in c…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: OM336 in Autoimmune Cytopenias [Phase 1]
Ouro Medicines reports a Phase 1 clinical trial of OM336 for autoimmune cytopenias, including warm and cold autoimmune hemolytic anemia and …
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: An Exploratory Study of Golidocitinib in Adult Patients With ITP [Phase 1, Phase 2]
An exploratory, early-phase clinical trial of golidocitinib for immune thrombocytopenia is planned and currently not recruiting.